Next 10 |
home / stock / brtx / brtx articles
The Dow Jones index closed lower by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern a...
The Dow Jones index closed lower by more than 50 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern ...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded up 0.11% to 38,42...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Tuesday. The Dow traded up 0.19% to 38,45...
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading lower by 55% to $1.56 during Tuesday’s session following Monday’s surge...
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the...
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Monday after the company presented preliminary clinical data from its ongoi...
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial re...
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected ...
News, Short Squeeze, Breakout and More Instantly...
BioRestorative Therapies Inc Company Name:
BRTX Stock Symbol:
OTCMKTS Market:
BioRestorative Therapies Inc Website:
2024-04-16 09:38:47 ET A New York-based %Biotech company is making major waves so far during Tuesday’s premarket hours after the company announced that the U.S. Food and Drug Administration (FDA) has cleared an important amendment to the protocol of the ongoing Phase 2 study inve...
2024-04-16 09:29:31 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- Palisade Bio, Inc. (Nasdaq: PALI ), Brera Holding (NASDAQ: BREA ), Peraso Inc. (NASDAQ: PRSO ), BioRestorative Therapies, Inc. (NASDAQ: BRTX ), and Intra-Cellular Ther...
2024-04-16 08:04:07 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- BioRestorative Therapies, Inc. (NASDAQ: BRTX ) stated that the U.S. Food and Drug Administration (“FDA”) cleared an important amendment to the protocol of the ongoing Phase 2 study investigating ...